An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Coherus BioSciences, Inc. will release its second quarter 2023 financial results on August 2, 2023, after market close. A conference call and webcast will be held to discuss the results and provide a general business update. The press release and related materials will be available on the company's website.
Positive
None.
Negative
None.
REDWOOD CITY, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced its second quarter 2023 financial results will be released after market close on Wednesday, August 02, 2023. Starting at 5:00 pm ET on August 02, 2023, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.
Conference Call Information
When: Wednesday, August 2nd, 2023, starting at 5:00 p.m. Eastern Time To access the conference call, please pre-register through the following link to receive dial-in information and a personal PIN to access the live call: https://register.vevent.com/register/BI3fdbdc05783442f89d11db6b94e74a28
The press release with the second quarter financial results and related materials will be available at https://investors.coherus.com prior to the start of the conference call.
A live and archived webcast will be available on the “Investors” section of the Coherus website at http://investors.coherus.com.
Please dial-in 15 minutes early to ensure a timely connection to the call.
Coherus Contact Information: Marek Ciszewski, J.D. SVP, Investor Relations IR@coherus.com
FAQ
When will Coherus BioSciences release its second quarter 2023 financial results?
Coherus BioSciences will release its second quarter 2023 financial results on August 2, 2023, after market close.
What will be discussed during the conference call and webcast?
The conference call and webcast will discuss the financial results and provide a general business update.
Where can I access the press release and related materials?
The press release and related materials will be available on the Coherus BioSciences website.
What is the contact information for Coherus BioSciences?
The contact information for Coherus BioSciences is Marek Ciszewski, J.D., SVP, Investor Relations, IR@coherus.com.
coherus biosciences is the leading biologics platform company solely focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medicines in regulated markets worldwide. founded in 2010, coherus is a late-stage biologics platform company focused on the global biosimilar market. headquartered in the san francisco bay area and composed of a team of industry veterans with decades of experience in pioneering biologics companies, our goal is to become a global leader in the biosimilar market by leveraging our team's collective expertise in key areas such as process science, analytical characterization, protein production and clinical-regulatory development. our commercialization partnerships include global pharmaceutical companies in europe, asia and latin america. biosimilars are intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases, with the potential to reduce costs and exp